Clinical Trial Update: Long-Term Efficacy in AMD of Rheopheresis in North America [NA]

View source ↗

Summary

Clinical trial update on the long-term efficacy of rheopheresis for age-related macular degeneration in North America; sponsor OccuLogix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Rheopheresis

Snippet

Sponsor: OccuLogix | Conditions: Macular Degeneration | NA | Status: UNKNOWN